Isthmus Partners LLC Invests $11.57 Million in Healthpeak Properties, Inc. (NYSE:DOC)

Isthmus Partners LLC bought a new position in Healthpeak Properties, Inc. (NYSE:DOC) in the third quarter, HoldingsChannel.com reports. The fund bought 506,019 shares of the real estate investment trust’s stock, valued at approximately $11,573,000.

A number of other hedge funds have also modified their holdings of DOC. HM Payson & Co. bought a new stake in Healthpeak Properties during the 3rd quarter worth approximately $25,000. S.A. Mason LLC bought a new stake in Healthpeak Properties during the 3rd quarter worth approximately $26,000. Rise Advisors LLC bought a new stake in Healthpeak Properties during the 3rd quarter worth approximately $29,000. Fortitude Family Office LLC bought a new stake in Healthpeak Properties during the 3rd quarter worth approximately $32,000. Finally, Barrett & Company Inc. bought a new stake in Healthpeak Properties during the 3rd quarter worth approximately $33,000. 93.57% of the stock is owned by institutional investors and hedge funds.

Analysts Set New Price Targets

A number of equities research analysts recently commented on DOC shares. Scotiabank increased their price target on Healthpeak Properties from $23.00 to $24.00 and gave the stock a “sector outperform” rating in a research report on Monday, September 9th. Wells Fargo & Company reiterated an “equal weight” rating and issued a $23.00 price objective (up from $22.00) on shares of Healthpeak Properties in a research report on Tuesday, October 1st. StockNews.com lowered Healthpeak Properties from a “hold” rating to a “sell” rating in a research report on Wednesday, October 30th. Evercore ISI increased their price objective on Healthpeak Properties from $25.00 to $26.00 and gave the company an “outperform” rating in a research report on Monday, September 16th. Finally, Royal Bank of Canada increased their price objective on Healthpeak Properties from $25.00 to $26.00 and gave the company an “outperform” rating in a research report on Monday, November 4th. One investment analyst has rated the stock with a sell rating, five have assigned a hold rating, ten have issued a buy rating and one has given a strong buy rating to the company. According to MarketBeat, Healthpeak Properties has an average rating of “Moderate Buy” and an average target price of $22.86.

Healthpeak Properties Stock Performance

Shares of Healthpeak Properties stock opened at $22.24 on Friday. The company has a market capitalization of $15.56 billion, a PE ratio of 47.32, a PEG ratio of 2.48 and a beta of 1.13. Healthpeak Properties, Inc. has a 12 month low of $16.01 and a 12 month high of $23.26. The company has a current ratio of 1.31, a quick ratio of 1.31 and a debt-to-equity ratio of 0.93. The stock’s fifty day simple moving average is $22.18 and its 200 day simple moving average is $21.21.

Healthpeak Properties (NYSE:DOC) last issued its quarterly earnings data on Thursday, October 24th. The real estate investment trust reported $0.12 EPS for the quarter, missing the consensus estimate of $0.44 by ($0.32). Healthpeak Properties had a return on equity of 3.53% and a net margin of 12.10%. The business had revenue of $700.40 million for the quarter, compared to analyst estimates of $682.51 million. During the same period in the previous year, the business posted $0.45 EPS. The business’s quarterly revenue was up 25.9% compared to the same quarter last year. On average, research analysts predict that Healthpeak Properties, Inc. will post 1.8 EPS for the current year.

Healthpeak Properties Dividend Announcement

The company also recently declared a quarterly dividend, which was paid on Friday, November 15th. Shareholders of record on Monday, November 4th were paid a $0.30 dividend. This represents a $1.20 annualized dividend and a dividend yield of 5.40%. The ex-dividend date was Monday, November 4th. Healthpeak Properties’s dividend payout ratio is 255.32%.

About Healthpeak Properties

Healthpeak Properties, Inc is a fully integrated real estate investment trust (REIT) and S&P 500 company. Healthpeak owns, operates, and develops high-quality real estate for healthcare discovery and delivery.